Implication of Serum Growth Differentiation Factor-15 Level in Patients with Renal Diseases

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2023 Apr 3

PMID 37010737

Authors

Shiori Kobayashi

Hidenori Yamazaki

Teruhiko Imamura

Hayato Fujioka

Kota Kakeshita

Tsutomu Koike

Koichiro Kinugawa

Affiliations

Soon will be listed here.

Abstract

Background: The synthesis of growth differentiation factor-15 (GDF-15) is induced by inflammation, hypoxia, and oxidative stress and is receiving great interest as a predictive biomarker for cardiovascular disease. However, its detailed impact on patients with renal disease remains uncertain.

Methods: Patients who underwent renal biopsy for evaluation of renal disease between 2012 and 2017 in our institute were prospectively included. Serum GDF-15 levels were measured and its association with baseline characteristics and its impact on the 3-year composites of renal prognosis (composites of > 1.5 folds of serum creatinine and renal replacement therapy) were investigated.

Results: A total of 110 patients (64 [42, 73] years old, 61 men) were included. The median serum GDF-15 level at baseline was 1885 (998, 3496) pg/mL. A higher serum GDF-15 level was associated with comorbidities including diabetes mellitus, anemia, renal impairment, and pathologic features including crescent formation, hyaline degeneration, and interstitial fibrosis (p < 0.05 for all). Serum GDF-15 level was a significant predictor of 3-year composite renal outcomes with an odds ratio per 100 pg/mL of 1.072 (95% confidence interval 1.001-1.103, p = 0.036) after adjustment for potential confounders.

Conclusions: Serum GDF-15 levels were associated with several renal pathological features and renal prognosis in patients with renal diseases.

Citing Articles

The role of GDF15 in attenuating noise-induced hidden hearing loss by alleviating oxidative stress.

Jiang Y, Zheng Z, Zhu J, Zhang P, Li S, Fu Y Cell Biol Toxicol. 2024; 40(1):79.

PMID: 39289208 PMC: 11408584. DOI: 10.1007/s10565-024-09912-2.

GDF15, an Emerging Player in Renal Physiology and Pathophysiology.

Lasaad S, Crambert G Int J Mol Sci. 2024; 25(11).

PMID: 38892145 PMC: 11172470. DOI: 10.3390/ijms25115956.

The Influence of Betulin Derivatives EB5 and ECH147 on the Expression of Selected TGFβ Superfamily Genes, , and , in Renal Proximal Tubule Epithelial Cells.

Kubica S, Szota-Czyz J, Strzalka-Mrozik B, Adamska J, Bebenek E, Chrobak E Curr Issues Mol Biol. 2023; 45(12):9961-9975.

PMID: 38132468 PMC: 10741875. DOI: 10.3390/cimb45120622.

References

Webster A, Nagler E, Morton R, Masson P . Chronic Kidney Disease. Lancet. 2016; 389(10075):1238-1252. DOI: 10.1016/S0140-6736(16)32064-5. View

Emmerson P, Duffin K, Chintharlapalli S, Wu X . GDF15 and Growth Control. Front Physiol. 2018; 9:1712. PMC: 6277789. DOI: 10.3389/fphys.2018.01712. View

Baek S, Eling T . Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases. Pharmacol Ther. 2019; 198:46-58. PMC: 7196666. DOI: 10.1016/j.pharmthera.2019.02.008. View

Mazagova M, Buikema H, van Buiten A, Duin M, Goris M, Sandovici M . Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes. Am J Physiol Renal Physiol. 2013; 305(9):F1249-64. DOI: 10.1152/ajprenal.00387.2013. View

Ho J, Hwang S, Wollert K, Larson M, Cheng S, Kempf T . Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem. 2013; 59(11):1613-20. PMC: 3972213. DOI: 10.1373/clinchem.2013.205716. View

Nair V, Robinson-Cohen C, Smith M, Bellovich K, Bhat Z, Bobadilla M . Growth Differentiation Factor-15 and Risk of CKD Progression. J Am Soc Nephrol. 2017; 28(7):2233-2240. PMC: 5491285. DOI: 10.1681/ASN.2016080919. View

Bansal N, Zelnick L, Shlipak M, Anderson A, Christenson R, Deo R . Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study. Clin Chem. 2019; 65(11):1448-1457. PMC: 6927328. DOI: 10.1373/clinchem.2019.305797. View

Na K, Kim Y, Chung H, Yeo M, Ham Y, Jeong J . Growth differentiation factor 15 as a predictor of adverse renal outcomes in patients with immunoglobulin A nephropathy. Intern Med J. 2017; 47(12):1393-1399. DOI: 10.1111/imj.13614. View

Frimodt-Moller M, von Scholten B, Reinhard H, Jacobsen P, Hansen T, Persson F . Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study. PLoS One. 2018; 13(4):e0196634. PMC: 5919646. DOI: 10.1371/journal.pone.0196634. View

10.

Breit S, Carrero J, Tsai V, Yagoutifam N, Luo W, Kuffner T . Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant. 2011; 27(1):70-5. DOI: 10.1093/ndt/gfr575. View

11.

Connelly P, Yan A, Nash M, Lok C, Gunaratnam L, Prasad G . Growth differentiation factor 15 is decreased by kidney transplantation. Clin Biochem. 2019; 73:57-61. DOI: 10.1016/j.clinbiochem.2019.07.013. View

12.

Yamamoto T, Watanabe T, Ikegaya N, Fujigaki Y, Matsui K, Masaoka H . Expression of types I, II, and III TGF-beta receptors in human glomerulonephritis. J Am Soc Nephrol. 1998; 9(12):2253-61. DOI: 10.1681/ASN.V9122253. View

13.

Fujigaki Y, Sun D, Fujimoto T, Suzuki T, Goto T, Yonemura K . Mechanisms and kinetics of Bowman's epithelial-myofibroblast transdifferentiation in the formation of glomerular crescents. Nephron. 2002; 92(1):203-12. DOI: 10.1159/000064469. View

14.

Yan C, Yu L, Zhang X, Shang J, Ren J, Fan J . Cytokine Profiling in Chinese SLE Patients: Correlations with Renal Dysfunction. J Immunol Res. 2020; 2020:8146502. PMC: 7568803. DOI: 10.1155/2020/8146502. View

15.

Perez-Gomez M, Pizarro-Sanchez S, Gracia-Iguacel C, Cano S, Cannata-Ortiz P, Sanchez-Rodriguez J . Urinary Growth Differentiation Factor-15 (GDF15) levels as a biomarker of adverse outcomes and biopsy findings in chronic kidney disease. J Nephrol. 2021; 34(6):1819-1832. DOI: 10.1007/s40620-021-01020-2. View

16.

Kim Y, Shin H, Chun Y, Park J . CST3 and GDF15 ameliorate renal fibrosis by inhibiting fibroblast growth and activation. Biochem Biophys Res Commun. 2018; 500(2):288-295. DOI: 10.1016/j.bbrc.2018.04.061. View

17.

Galassi A, Ciceri P, Bono V, Magagnoli L, Sala M, Artioli L . Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19. Biomedicines. 2022; 10(12). PMC: 9775159. DOI: 10.3390/biomedicines10123251. View

18.

Kastritis E, Papassotiriou I, Merlini G, Milani P, Terpos E, Basset M . Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis. Blood. 2018; 131(14):1568-1575. DOI: 10.1182/blood-2017-12-819904. View